Vimarsana
Biggest News Aggregation in the World

Page 8 - Repurchase Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Repurchase Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Repurchase Program Today - Breaking & Trending Today

BlackRock Closed-End Funds have Repurchased approximately $1.3 Billion of Shares since the Share Repurchase Program's Inception -January 11, 2024 at 04:31 pm EST - Vimarsana News

BlackRock Closed-End Funds have Repurchased approximately $1.3 Billion of Shares since the Share Repurchase Program's Inception -January 11, 2024 at 04:31 pm EST

BlackRock Advisors, LLC released today share repurchase activity for certain BlackRock-advised closed-end funds during the quarter ended December 31, 2023. The Funds have authorized open market...

Marti Announces up to $2.5M Share Repurchase Program - Vimarsana News

Marti Announces up to $2.5M Share Repurchase Program

Türkiye’s leading mobility super app Marti Technologies, Inc. today announced a share repurchase program. The Company’s Board of Directors today authorized a share repurchase program under...

Abacus Life Repurchases $1.9 Million of Stock in First 30 Days of Program - Vimarsana News

Abacus Life Repurchases $1.9 Million of Stock in First 30 Days of Program

ORLANDO, Fla., Jan. 09, 2024 -- Abacus Life, Inc. , a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products,...

The Bull Case For Jabil Inc. - Jabil (NYSE:JBL) - Vimarsana News

The Bull Case For Jabil Inc. - Jabil (NYSE:JBL)

With Quiver Quantitative’s recent institutional holdings data, we can see that hedge funds and asset managers have been increasing their holdings in Jabil Inc. (NYSE: JBL).

Exelixis Announces Preliminary Fiscal Year 2023 Financial Results, Provides 2024 Financial Guidance, and Outlines Key Priorities and Milestones for 2024 - Vimarsana News

Exelixis Announces Preliminary Fiscal Year 2023 Financial Results, Provides 2024 Financial Guidance, and Outlines Key Priorities and Milestones for 2024

– Cabozantinib franchise achieves approximately $1.630 billion in preliminary U.S. net product revenues for fiscal year 2023 – – Fiscal year 2024 net product revenues guidance of $1,650...